scPharmaceuticals Inc. announced the appointment of Sara Bonstein to its Board of Directors. Ms. Bonstein fills the vacancy created from Dorothy Coleman’s resignation from the Board of Directors. Ms. Coleman stepped down from the Board after serving since April 2015. Ms. Bonstein has over 15 years of operational and financial leadership experience in the life sciences industry. She currently holds the position of Chief Financial Officer of Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Previously, Ms. Bonstein has served as Chief Financial Officer, Chief Operating Officer and Corporate Secretary at OncoSec Medical and as the Chief Financial Officer, Secretary, Treasurer, and Executive Vice President at Advaxis Inc. Prior to these roles, Ms. Bonstein held several roles at Eli Lilly & Company and Johnson & Johnson. Ms. Bonstein holds a BS in Finance from The College of New Jersey and an MBA from Rider University.